Publications by authors named "Susan L Cusack"

Claim this Profile
A
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Carolyn D Britten, Elizabeth Garrett-Mayer, Steven H Chin, Keisuke Shirai, Besim Ogretmen, Susan L Cusack

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl(®)) for postoperative analgesia in women following total abdominal hysterectomy.
Susan L Cusack, Philip Reginald, Lisa Hemsen, Emmanuel Umerah

J Pain Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery.
Lisa Hemsen, Susan L Cusack, Harold S Minkowitz, Michael E Kuss

J Pain Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl(®)) with the ON-Q PainBuster(®) Post-op Pain Relief System following open gynecological surgery.
Susan L Cusack, Harold S Minkowitz, Michael Kuss, Mark Jaros, Lisa Hemsen

J Pain Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of XaraColl(®), a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies.
Susan L Cusack, Mark Jaros, Michael Kuss, Harold S Minkowitz, Peter Winkle

J Pain Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis